BioSig CEO says PURE EP System is “gaining momentum” as it adds new healthcare facilitiesProactive Investors • 03/29/21
BioSig Issues Shareholder Letter with Corporate Update on Recent Achievements and Anticipated Milestones for 2021GlobeNewsWire • 03/29/21
BioSig CEO Kenneth L. Londoner to Present at the Oppenheimer 31st Annual Healthcare ConferenceGlobeNewsWire • 03/10/21
BioSig CEO Kenneth L. Londoner to Present at the 33rd Annual Virtual ROTH ConferenceGlobeNewsWire • 03/09/21
BioSig Technologies says US Patent Office allows utility patent that its subsidiary NeuroClear had exclusively licensed from the Mayo FoundationProactive Investors • 03/04/21
BioSig Technologies appoints Brenda Castrodad to lead its Human Resources departmentProactive Investors • 02/16/21
BioSig Technologies says it has entered into three new evaluation agreements for its PURE EP SystemProactive Investors • 02/10/21
Major Medical Centers Enter into Installation Agreements for Evaluation of BioSig PURE EP™ SystemsGlobeNewsWire • 02/10/21
BioSig CEO Kenneth L. Londoner to Present at the Virtual Investor Conference Small and Microcap ShowcaseGlobeNewsWire • 01/27/21
BioSig Deploys Vuzix M400 Smart Glasses to Offer Remote Servicing Capabilities in Compliance with COVID-19 Travel RestrictionsGlobeNewsWire • 01/13/21
BioSig Conducts First Patient Cases with PURE EP(tm) System at Memorial Hospital of South Bend, IndianaGlobeNewsWire • 01/12/21
BioSig CEO Kenneth L. Londoner to Present at the Sidoti Winter 2021 Investor ConferenceGlobeNewsWire • 01/06/21
BioSig's Division NeuroClear Technologies Signs a Research Agreement with the University of MinnesotaGlobeNewsWire • 12/18/20
BioSig CEO Kenneth L. Londoner to Present at the 13th Annual LD Micro Main Event ConferenceGlobeNewsWire • 12/10/20
BioSig Technologies, Inc. (BSGM) CEO Ken Londoner on Business Development Update Conference Call (Transcript)Seeking Alpha • 11/19/20